158. Essentials Of Pharmacology

You are here: Home / Uncategorized / 158. Essentials Of Pharmacology

158. Essentials Of Pharmacology

158. Essentials Of Pharmacology

 

 

CATEGORY: Medical & Medicine – 500 Courses

COURSE NUMBER: 158

FEES: 555/- INR only

CERTIFICATE VALIDITY: Lifetime

CERTIFICATES DELIVERY: In 48 hours

BOOKS/ MANUALS: Pages

Syllabus

Part I Basic Pharmacologic Principles
1 Pharmacokinetics and Pharmacodynamics of Anesthetics . . . . . . . . 3
Patrick Chan and James A. Uchizono
2 A Review of Mechanisms of Inhalational Anesthetic Agents. . . . . . . 49
Elizabeth A.M. Frost
3 Pharmacokinetics, Pharmacodynamics, and Physical Properties
of Inhalational Agents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61
Hanjo Ko, Alan David Kaye, and Richard D. Urman
4 Principles of Total Intravenous Anesthesia . . . . . . . . . . . . . . . . . . . . . 73
Basavana Gouda Goudra and Preet Mohinder Singh
5 Perioperative Considerations in Pharmacology . . . . . . . . . . . . . . . . . 87
Angela Vick, Amaresh Vydyanathan, Tarang Safi ,
and Karina Gritsenko
Part II Drug Classes
6 Anesthetic Induction Agents. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
David Hirsch, Charles Fox, and Alan David Kaye
7 Analgesics: Opiate Agonists, Mixed Agonists/Antagonists,
and Antagonists for Acute Pain Management. . . . . . . . . . . . . . . . . . . 113
Orlando J. Salinas and Christopher K. Merritt
8 Analgesics: Opioids for Chronic Pain Management
and Surgical Considerations. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 125
Roy Esaki and Alex Macario
9 Nonopioid Analgesic and Adjunct Drugs . . . . . . . . . . . . . . . . . . . . . . 147
Mary Bekhit, Kaveh Navab, Andrew Ghobrial, and Tod Aust

10 Benzodiazepines and Muscle Relaxants. . . . . . . . . . . . . . . . . . . . . . . . 167
Joyce C. Lo and Alan David Kaye
11 Pharmacology of Local Anesthetics . . . . . . . . . . . . . . . . . . . . . . . . . . . 179
Neesa Patel and Alireza Sadoughi
12 Neuromuscular Blockers. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 195
Gabriel Goodwin and Vilma Joseph
13 Reversal Agents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 205
Andrew Sim and Angela Vick
14 Drugs Acting on the Autonomic Nervous System . . . . . . . . . . . . . . . . 219
John Pawlowski
15 Antihypertensives, Diuretics, and Antidysrhythmics. . . . . . . . . . . . . 235
Ryan Field
16 Peripheral Vasodilators. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 257
Ratan K. Banik and Jay S. Berger
17 Nitric Oxide and Pulmonary Vasodilators. . . . . . . . . . . . . . . . . . . . . . 275
Michelle Schlunt
18 Asthma and COPD Agents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 295
Alexis Appelstein and Mabel Chung
19 Hormones, Part 1: Thyroid and Corticosteroid Hormones. . . . . . . . 313
Joe C. Hong
20 Hormones Part 2: Insulin and Other Glucose- Controlling
Medications. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 327
Kumar Vivek, Shamantha Reddy, and Justo Gonzalez
21 Antacids, Gastrointestinal Prokinetics,
and Proton Pump Inhibitors. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 345
Sunitha Kanchi Kandadai and Mark V. Boswell
22 Histamine Modulators. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 365
Michael Yarborough and Judy G. Johnson
23 Central Nervous System Stimulants. . . . . . . . . . . . . . . . . . . . . . . . . . . 381
Eric S. Hsu
24 Anticoagulant Drugs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 397
Subarna Biswas, Jun Sasaki, and Michelle Braunfeld
25 Hemostatic Agents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 415
John S. McNeil and M. Dustin Boone
26 Blood, Blood Products, and Substitutes. . . . . . . . . . . . . . . . . . . . . . . . 421
Molly Chung, Laura Mayer, Hamid Nourmand, Michelle You,
and Jonathan S. Jahr

27 Antipyretics: Acetaminophen, Arachidonic Acid Agents,
and COX1 and COX2 Inhibitors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 433
My Tu, Karina Gritsenko, Boleslav Kosharskyy,
and Naum Shaparin
28 Antiemetic Agents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 445
Aaron M. Fields
29 Antiepileptic Agents. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 453
Angelika Kosse and Heesung Kang
30 Neuropharmacologic Agents for Neurologic Conditions . . . . . . . . . . 485
Maria Bustillo and Tricia Vecchione
31 Chemotherapeutic Agents. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 503
Adrienne B. Warrick, Karina Gritsenko, and Melinda Aquino
32 Antimicrobial Agents. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 525
Rebecca Johnson, Richard Lancaster, and Timothy Ku
33 Herbal Medications and Vitamin Supplements . . . . . . . . . . . . . . . . . 549
Philip Gregory, Andrew Abe, and Darren Hein
34 Minerals and Electrolytes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 563
Amit Prabhakar, Alan David Kaye, and Amir Baluch
35 Disinfection Agents and Antiseptics. . . . . . . . . . . . . . . . . . . . . . . . . . . 573
Valeriy Kozmenko, Rudolph R. Gonzales Jr., James Riopelle,
and Alan David Kaye
36 Psychopharmacologic Agents and Psychiatric
Drug Considerations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 581
Charles Fox, Alan David Kaye, and Henry Liu
37 Cocaine, Methamphetamine, MDMA, and Heroin. . . . . . . . . . . . . . . 595
Ethan O. Bryson
Part III Clinical Subspecialties
38 Cardiac Surgery. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 609
Henry Liu, Hong Yan, Ming Chen, Mingbing Chen, Charles Fox,
and Alan David Kaye
39 The Intensive Care Unit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 645
Brian O’Gara and Shahzad Shaefi
40 Enteral and Parenteral Nutrition . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 661
Jillian Redgate and Sumit Singh
41 Obstetrics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 677
Laura Mayer, Richard Hong, and Jeff Bernstein

42 Pediatrics. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 697
Vanessa Ng, Karina Gritsenko, and Rebecca Lintner
43 Neurologic Surgery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 707
Allison Spinelli and Robyn Landy
44 Liver Disease and Liver Transplantation . . . . . . . . . . . . . . . . . . . . . . 719
Gundappa Neelakanta and Victor Xia
Part IV Special Topics
45 Black Box FDA Warnings and Legal Implications. . . . . . . . . . . . . . . 741
Meghan Lane-Fall
46 Drug-Induced QT Prolongation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 753
Elizabeth A. Valentine, Alan David Kaye, Jackie V. Abadie,
and Adam M. Kaye
47 Drugs and Cancer Propagation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 767
Amit Prabhakar, Alan David Kaye, and Richard D. Urman
48 Lipid-Lowering Agents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 783
Scott D. Friedman and Brian McClure
49 Serotonin Syndrome . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 797
Julie A. Gayle, Jacqueline Volpi Abadie, Adam M. Kaye,
and Alan David Kaye
Part V New Vistas in Pharmacology
50 Novel Psychoactive Substances: Synthetic Cathinones
and Cannabinoid Receptor Agonists . . . . . . . . . . . . . . . . . . . . . . . . . . 811
Ethan O. Bryson
51 New Vistas in Anesthetics, IV Induction Agents. . . . . . . . . . . . . . . . . 819
John Pawlowski
52 New Vistas in Neuromuscular Blockers. . . . . . . . . . . . . . . . . . . . . . . . 827
Matthew T. Murrell and John J. Savarese
53 Patient-Controlled Analgesia: The Importance of Effector
Site Pharmacokinetics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 837
Pamela P. Palmer and Mike A. Royal
54 Understanding Anesthesia-Induced Memory Loss. . . . . . . . . . . . . . . 847
Agnieszka A. Zurek and Beverley A. Orser
55 Novel Targets of Current Analgesic Drug Development . . . . . . . . . . 859
Jeffrey A. Katz and Honorio T. Benzon
Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 875

……………………………………………………………………………………………………………………………………………………………………………………………………………………

 

Medifit  Courses Demo Certificate 

48 hours delivery

| International acceptance | Medical based | Job oriented | Lifetime validity | Most economical |

 

555 INR Demo Certificate – 2 months duration

Demo Certificate – 6 months duration

48 hours delivery after fees payment

48 hours delivery after fees payment

 

Medifit 48 hours Delivery

  Get your Certificates delivered by online mode in 48 hours after Fees payment. We try to deliver certificates in 24 hours, but the committed delivery hours are 48. Its,

Pay Today &
get Tomorrow

procedure, only by Medifit.

LIFETIME VALIDITY

Medifit issues Lifetime validity certificates for all Online Courses provided. No need to renew the certificates every 2 or 3 years. All Courses Certificates of Medifit are having Lifetime Validity. No need to renew these certificates every 2 or 3 years.

 

What makes the certificates of Medifit to get it recognized Internationally?

Vast number of students applying for Job in international market of Fitness through Medifits Online Courses Certificates. And most importantly, the Medical standards maintained, helps to acquire jobs internationally. This gives very strong International acceptance to Certificates of Medifit Courses.

 

ABOUT MEDIFIT ACADEMY CERTIFICATION COURSE:

Medifit Education Online Academy is an innovative, digital and engaging education platform that delivers fast track accredited courses and skills development courses instantly online, with no time limits, enabling individuals to study anywhere and anytime. We are proud to offer international standard courses that have helped our students build their careers across the globe.

HOW DO MEDIFIT ONLINE CERTIFICATE COURSES HELP?

Short term Professional Courses International Standards courses Opens Global opportunities Career defining Courses Skill Development Programmes Knowledge in short span Learn at your own pace Certification of Completion Immediate Earning Opportunities Positive Social Impact Optimistic Psychological Benefits Improved Standard of Living Study from anywhere & anytime Very Economical Fees

Leave a Reply